News Releases
- F. Hoffmann-La Roche Announces Third Quarter Sales 2025
- Alecensa Extends Median Overall Survival to Over 80 Months in ALK-Positive Metastatic Non-Small Cell Lung Cancer
- Roche’s Announcement Regarding Tecentriq (Presentation of Latest Data as an Adjuvant Treatment in Muscle-Invasive Bladder Cancer at ESMO)
Science and Technology
Science and Technology
Careers at Chugai
Careers at Chugai
Videos
CPR celebrates 10th Anniversary
